These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29532287)

  • 1. Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.
    Strupp M; Kraus L; Schautzer F; Rujescu D
    J Neurol; 2018 Oct; 265(Suppl 1):80-85. PubMed ID: 29532287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.
    Strupp M; Hupert D; Frenzel C; Wagner J; Hahn A; Jahn K; Zingler VC; Mansmann U; Brandt T
    Acta Otolaryngol; 2008 May; 128(5):520-4. PubMed ID: 18421605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.
    Monzani D; Barillari MR; Alicandri Ciufelli M; Aggazzotti Cavazza E; Neri V; Presutti L; Genovese E
    Acta Otorhinolaryngol Ital; 2012 Dec; 32(6):393-403. PubMed ID: 23349559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series.
    Lezius F; Adrion C; Mansmann U; Jahn K; Strupp M
    Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1237-1240. PubMed ID: 21626121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.
    Mira E; Guidetti G; Ghilardi L; Fattori B; Malannino N; Maiolino L; Mora R; Ottoboni S; Pagnini P; Leprini M; Pallestrini E; Passali D; Nuti D; Russolo M; Tirelli G; Simoncelli C; Brizi S; Vicini C; Frasconi P
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):73-7. PubMed ID: 12582782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
    Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
    PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term therapy of Ménière's disease. Comparison of the effects of betahistine dihydrochloride and hydrochlorothiazide].
    Petermann W; Mulch G
    Fortschr Med; 1982 Mar; 100(10):431-5. PubMed ID: 7040186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine.
    Teggi R; Gatti O; Sykopetrites V; Quaglieri S; Benazzo M; Bussi M
    Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):349-53. PubMed ID: 25709150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Dose Betahistine in Combination With Selegiline Increases Cochlear Blood Flow in Guinea Pigs.
    Kloos B; Bertlich M; Spiegel JL; Freytag S; Lauer SK; Canis M; Weiss BG; Ihler F
    Ann Otol Rhinol Laryngol; 2023 May; 132(5):519-526. PubMed ID: 35656811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betahistine in Ménière's Disease or Syndrome: A Systematic Review.
    Van Esch B; van der Zaag-Loonen H; Bruintjes T; van Benthem PP
    Audiol Neurootol; 2022; 27(1):1-33. PubMed ID: 34233329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière's disease compared with betahistine pharmacotherapy.
    Molnár A; Maihoub S; Tamás L; Szirmai Á
    J Int Med Res; 2021 Apr; 49(4):300060520985647. PubMed ID: 33845616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease.
    Albu S; Chirtes F; Trombitas V; Nagy A; Marceanu L; Babighian G; Trabalzini F
    Am J Otolaryngol; 2015; 36(2):205-9. PubMed ID: 25510210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the efficacy and safety of a new modified-release betahistine formulation in the treatment of vestibular vertigo and Meniere's disease].
    Parfenov VA; Zamergrad MV; Kazei DV; Nauta J
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12):42-48. PubMed ID: 33459540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative Treatment Possibilities of Ménière Disease, Involving Vertigo Diaries.
    Molnár A; Maihoub S; Tamás L; Szirmai Á
    Ear Nose Throat J; 2021 Aug; 100(7):536-542. PubMed ID: 31617407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
    Nauta JJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine hydrochloride in Méniére's disease.
    Frew IJ; Menon GN
    Postgrad Med J; 1976 Aug; 52(610):501-3. PubMed ID: 790351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betahistine for Menière's disease or syndrome.
    James AL; Burton MJ
    Cochrane Database Syst Rev; 2001; 2001(1):CD001873. PubMed ID: 11279734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.